Sign in

Aideen Ryan, BSc, PhD

@aideenryan.bsky.social
1.6K followers 641 following 9 posts

Tumour Immunology enthusiast. Group leader at University of Galway. Interested in fibroblasts, stromal cells and anti-tumour immunity. All views are my own.

PostsRepliesMedia
Reposted by Aideen Ryan, BSc, PhD
University of Galway @uniofgalway.bsky.social · 20/10/2025
Researchers at the University of Galway have revealed the results of a world-first study into how bowel cancer shuts down the immune system, and how this can be reversed to improve treatment. 🧬 Read more 👉 jitc.bmj.com/lookup/doi/10.1136/jit…
051
Reposted by Aideen Ryan, BSc, PhD
Emil Lou, MD, PhD, FACP, FASCO @cancerassassin1.bsky.social · 26/04/2025
Abstract drop - CT269 - First-in-human trial in patients with metastatic colorectal cancer using CRISPR-engineered tumor infiltrating lymphocytes in which the intracellular immune checkpoint CISH is inhibited #AACR25 eppro02.ativ.me/appinfo.php?... #AACR25
eppro02.ativ.me
AACR 2025 Annual Meeting Guide
041
Reposted by Aideen Ryan, BSc, PhD
Nick Vitanza @nickvitanza.bsky.social · 22/04/2025
Thrilled to have secured Breakthrough Therapy Designation. This will accelerate our ability to bring #CARTcells to more children with #DIPG and brain & spinal cord tumors.
1143
Reposted by Aideen Ryan, BSc, PhD
Edwards Lab @labedwards.bsky.social · 26/03/2025
Last week, the 1st Annual IMPACT conference took place on the shores of Loch Lomond 📍🤩
189
Reposted by Aideen Ryan, BSc, PhD
Edwards Lab @labedwards.bsky.social · 26/03/2025
With 5 distinct research groups led by @joedwardswwcrc.bsky.social, Campbell Roxburgh, Nigel Jamieson, Colin Steele, and @mcsorleystephen.bsky.social, IMPACT provides a human tissue-based translational research infrastructure in Glasgow, in collaboration with @drpipdunne.bsky.social and Xiao Fu! 🤝
163
Aideen Ryan, BSc, PhD @aideenryan.bsky.social · 18/03/2025
Our latest story on the impact of the Sia/Siglec axis and stromal cells in colorectal cancer is online - led by Aoise O’Neill. We identified tgat stromal sualylation shaoes innate immune phenotypes and function. www.biorxiv.org/content/10.1...
biorxiv.org
Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid/Siglec axis
The immunosuppressive tumour microenvironment (TME) reduces immune response effectiveness in stromal-rich tumours, including CMS4 colorectal cancer (CRC). Mesenchymal stromal cells (MSCs), precursors ...
160
Reposted by Aideen Ryan, BSc, PhD
Ashani Weeraratna @ashi-w.bsky.social · 18/02/2025
Kudos to the @theaacr.bsky.social for making it easy to reach out to your representatives. Nice to see courage and action. nam02.safelinks.protection.outlook.com?url=https%3A...
nam02.safelinks.protection.outlook.com
AACR Legislative Action Center
Directly contact your elected officials about the importance of cancer research, the need for continued funding and the latest lifesaving breakthroughs. In the United States, you can do so by sending ...
0219
Reposted by Aideen Ryan, BSc, PhD
uniofgalwaycmnhs.bsky.social @uniofgalwaycmnhs.bsky.social · 04/02/2025
@uniofgalway.bsky.social researcher helps the body help itself in the fight against cancer. @aideenryan.bsky.social is looking at mechanisms in supportive tissue cells to enhance the body’s immune response to cancers. tinyurl.com/3x44aa8p
tinyurl.com
This researcher helps the body help itself in the fight against cancer
University of Galway’s Dr Aideen Ryan is looking at mechanisms in supportive tissue cells with the aim of enhancing the body’s immune response to cancers.
081
Reposted by Aideen Ryan, BSc, PhD
Silicon Republic @siliconrepublic.bsky.social · 28/01/2025
University of Galway’s Dr Aideen Ryan is looking at mechanisms in supportive tissue cells to enhance the body’s immune response to cancers.
siliconrepublic.com
This researcher helps the body help itself in the fight against cancer
University of Galway’s Dr Aideen Ryan is looking at mechanisms in supportive tissue cells with the aim of enhancing the body’s immune response to cancers.
081
Reposted by Aideen Ryan, BSc, PhD
Itai Yanai @itaiyanai.bsky.social · 26/01/2025
Failure is always in the background of any creative project; when the experiments are not working or the results don’t seem to make sense. But for discovery, you can’t deny yourself the permission to fail, and we should better teach failure in all its glory.
110626
Reposted by Aideen Ryan, BSc, PhD
Crystal Rogers, PhD @rogerslabucd.bsky.social · 14/01/2025
Grant has been reimagined, rewritten, read by others, revised and submitted! Fingers crossed that it does well. On to the next challenge we go, Sisyphus! I get knocked down, I get back up again! 💪🏽
media.tenor.com
a large rock is rolling down the side of a rocky hill
Alt: a large rock is rolling down the side of a rocky hill and being pushed back up by Sisyphus
8623
Reposted by Aideen Ryan, BSc, PhD
Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 11/12/2024
Great slide highlighting not only are TILs predictive of pCR...it also translates to being prognostic beyond pCR for good outcome and DFS. Seems like we have a LOT of data on TILs now, why aren't they standardly provided on path reports???🧐 #SABCS24 @oncoalert.bsky.social @sabcs.bsky.social
2197
Reposted by Aideen Ryan, BSc, PhD
Bernard A. Fox @bernardafox.bsky.social · 07/12/2024
#Bridge2024 coming to a close! Saturday, December 7th 2024 @2:10 pm and we are entering the last session/will cover 1st line #immunotherapy, salvage, igniting change in #cancer #vaccine development, combo IO, #PD1 refractory & more @sitcancer.bsky.social #MSD #BIOTECH #BMS #Merck #Regeneron #UbiVac
181
Reposted by Aideen Ryan, BSc, PhD
Bernard A. Fox @bernardafox.bsky.social · 06/12/2024
WORK HARD, PLAY HARD! Celebrate your success & commiserate over failures / #Immunotherapy #Bridge2024 is over & the 15th #Melanoma Bridge has started. Great being in #Napoli with so many friends. PAscierto, Choueiri, Hamid, Tawbi @samirkhleif.bsky.social , Bruno, Guerrero, @sitcancer.bsky.social
0102
Reposted by Aideen Ryan, BSc, PhD
Bernard A. Fox @bernardafox.bsky.social · 06/12/2024
Discussion of Prof Mitch Levesque data / Amazing single cell #melanoma phenotypes/ can it explain resistance? Thinks metabolic signature? Functional data more important #Bridge2024 @melanomaresearch.bsky.social @impactmelanoma.bsky.social @sitcancer.bsky.social #FinishCancer #PAscierto
011
Reposted by Aideen Ryan, BSc, PhD
Bernard A. Fox @bernardafox.bsky.social · 06/12/2024
Prof Michael Postow #melanoma #immunotherapy Expert @mskcancercenter.bsky.social talks #neoadjuvant treatment.. How many doses of checkpoint blockade? Can we reduce toxicity & maintain efficacy? @sitcancer.bsky.social #Bridge2024 @impactmelanoma.bsky.social @melanomaresearch.bsky.social
131
Reposted by Aideen Ryan, BSc, PhD
Carl Zimmer @carlzimmer.com · 05/12/2024
More video! Here's my conversation with Nobel-prize winner Katalin Kariko, who pioneered mRNA vaccines. youtu.be/5_9ccDmX3hs?...
youtu.be
City of Science: Katalin Karikó in Conversation with Carl Zimmer
YouTube video by CUNY Graduate Center
25419
Aideen Ryan, BSc, PhD @aideenryan.bsky.social · 05/12/2024
Congratulations Sid, Courtney and @drpipdunne.bsky.social on your publication in Scientific Reports- a really useful resource to help the field ensure more robust discovery approach using dualGSEA. @researchireland.bsky.social @universityofgalway.bsky.social www.nature.com/articles/s41...
nature.com
Dual gene set enrichment analysis (dualGSEA); an R function that enables more robust biological discovery and pre-clinical model alignment from transcriptomics data - Scientific Reports
Scientific Reports - Dual gene set enrichment analysis (dualGSEA); an R function that enables more robust biological discovery and pre-clinical model alignment from transcriptomics data
051
Reposted by Aideen Ryan, BSc, PhD
The Lund Lab @thelundlab.bsky.social · 30/11/2024
We have a great line up and we are super excited by all the abstracts we have recieved! Register by Dec. 12 (11:59pm MST) to save $200 USD & access 2 meetings for the price of one! Join us in Vancouver in Feb. for the T Cell Differentiation in Tissue Microenvironments Keystone. hubs.la/Q02ZKxQV0
t.co
https://hubs.la/Q02ZKxQV0
0154
Reposted by Aideen Ryan, BSc, PhD
Bernard A. Fox @bernardafox.bsky.social · 30/11/2024
💥40 years ago today a 33 y/o dying of #metastatic #melanoma got #LAK & #IL-2 & all #cancer went away! Dr. S.A. #Rosenberg (SAR) had the #immune system #cure a patient/I was in SAR’s lab 85-90/incredible era & energy/Great story in @usatoday.com apple.news/AIcm-M7cDQ-O... @sitcancer.bsky.social
apple.news
Opinion | Her medical file read 'death imminent.' His treatment plan changed cancer forever. | Opinion — USA TODAY
Immunotherapy is the brightest new weapon in fight against cancer. Thank Dr. Steven Rosenberg, who 40 years ago successfully used it to save a life.
15010
Aideen Ryan, BSc, PhD @aideenryan.bsky.social · 28/11/2024
Delighted to celebrate Eileen’s, Aoife’s and Jiemen’s graduations yesterday. Three stellar PhD students who were a pleasure to supervise and work with. Wishing them all of the best in their future careers. @researchireland.bsky.social
060
Reposted by Aideen Ryan, BSc, PhD
Nuria Lopez-Bigas @nlbigas.bsky.social · 27/11/2024
Only a subset of patients respond to immunotherapy Why? Which ones? We conducted an unbiased analysis of response biomarkers and found that hundreds of possible biomarkers collapse into five latent, orthogonal factors that underlie immunotherapy response. www.nature.com/articles/s41...
413246
Reposted by Aideen Ryan, BSc, PhD
Sara Zanivan @zanivanlab.bsky.social · 26/11/2024
Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment www.cell.com/cell-reports...
cell.com
Cancer-associated fibroblasts maintain critical pancreatic cancer cell lipid homeostasis in the tumor microenvironment
Han et al. identify crosstalk between CAFs and pancreatic cancer cells under hypoxia and nutrient scarcity. Lysophosphatidylcholines (LPCs), as the key mediators, can be utilized for phosphatidylcholi...
0154
Reposted by Aideen Ryan, BSc, PhD
Johanna Joyce @johannajoyce.bsky.social · 25/11/2024
Women are under-represented at senior levels in #academia globally, & across all #science 🧪 disciplines, as shown by these "scissor-shaped curves" ✂️ So how can we ever achieve #gender #equality? We discuss various strategies in this #Cell Commentary #WomeninSTEM www.cell.com/cell/fulltex... 🧵 1/
361192596
Reposted by Aideen Ryan, BSc, PhD
CÚRAM Research Ireland Centre for Medical Devices @curamdevices.bsky.social · 22/11/2024
Great article w/ CÚRAM FI Sharon Glynn at Universityof Galway in TechCentral this week explaining her work on breast cancer and triple negative breast cancer in particular.. Read more at techcentral.ie/focus-on-res... #breastcancerresearch #NOCANCERNETWORK @researchireland.bsky.social
techcentral.ie
Focus on research: Prof Sharon Glynn, University of Galway - TechCentral.ie
Prof Sharon Glynn is a Professor in Pathology at the University of Galway working with Cúram, the Research Ireland centre for medical devices. In this interview she talks about advancements in the und...
051
Reposted by Aideen Ryan, BSc, PhD
John Ebos @ebos.bsky.social · 25/11/2024
The hallmarks of cancer immune evasion
cell.com
The hallmarks of cancer immune evasion
Cancer cells often evade the host immune system, challenging the effectiveness of immunotherapy. In this comprehensive review, Galassi et al. summarize key mechanisms of immune evasion within the “thr...
04416
Reposted by Aideen Ryan, BSc, PhD
Christian Frezza @frezzalab.bsky.social · 24/11/2024
Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma - Nature 🧪 www.nature.com/articles/s41...
nature.com
Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma - Nature
The prodrug gliocidin effectively kills glioblastoma cells by targeting de novo purine synthesis, improving survival in mouse models.
2229
Aideen Ryan, BSc, PhD @aideenryan.bsky.social · 18/11/2024
Interesting role for PGE2 - EP2/4 axis in immunosuppression in tumours www.nature.com/articles/s41...
nature.com
Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells - Nature Communications
Mechanisms of prostaglandin E2 (PGE2)-mediated immunosuppression in the tumor microenvironment (TME) have been previously reported. Here, the authors profile PGE2 functions in human cancer, suggesting...
060
Aideen Ryan, BSc, PhD @aideenryan.bsky.social · 18/11/2024
Last of the summer tomatoes! Made soup and crusty bread. The simple pleasures!
040